Healthy and COPD Participants to Evaluate the Efficacy and Safety of Inhaled TV46017
- Study Title
- Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017
- Teva Identifier
- TV46017-COPD-10046
- ClinicalTrials.gov Identifier
- NCT02315131
- Study Status
- Terminated
- Trial Condition(s)
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: TV46017 | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 20 Years to 75 Years
- Trial Duration
- 03/01/2015 - 08/01/2015
- Phase
- Phase 1
